AUTL
Autolus Therapeutics
AUTL
AUTL
64 hedge funds and large institutions have $195M invested in Autolus Therapeutics in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
9% less funds holding
Funds holding: 70 → 64 (-6)
36% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 14
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
64
Holding in Top 10
1
Calls
$72K
Puts
$13K
Top Buyers
| 1 | +$3.13M | |
| 2 | +$1.39M | |
| 3 | +$871K | |
| 4 |
Millennium Management
New York
|
+$432K |
| 5 |
IAM
Innovis Asset Management
Chicago,
Illinois
|
+$232K |
Top Sellers
| 1 | -$2.35M | |
| 2 | -$2.3M | |
| 3 | -$1.19M | |
| 4 |
AC
Armistice Capital
New York
|
-$1.02M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$950K |